What triggered Morpho's latest price surge

Traders Union
All News
Crypto
Morpho surges 10.80% today to $2.41

Highlights

Morpho's open interest surged 11% and investor votes overwhelmingly back further gains, signaling strong fundamental momentum.
Long positions now make up 54% of market volume, lifting the long/short ratio to 1.27 and indicating bullish sentiment.
Technicals show a bullish trend with MORPHO/USD expected to trade between $2.19 and $2.56; overbought signals suggest potential short-term consolidation.

Investor positioning shifts bullish as interest and long bets accelerate

Morpho has seen a significant surge in open interest by 11% along with a positive funding rate of 0.0053%, indicating greater investor engagement in its markets. Approximately 38,700 investors voted unanimously in favor of further gains for the asset. Long positions accounted for 54% of perpetual market volume, lifting the Long/Short ratio to 1.27, and reflecting increased trading activity and capital allocation toward Morpho.

Anton Kharitonov, expert at Traders Union, sees a strong bullish structure for Morpho, yet remains cautious about the sustainability of this move. He highlights that the price’s distance above all key moving averages signals overextension. Rising open interest and positive funding point to overheated sentiment, as does the unanimous investor vote for more gains — a potential contrarian warning. Momentum indicators, like the RSI and CCI, flashing overbought and a volatile upside gap, suggest risk of a short-term correction if profit-taking accelerates. "Despite the bullish setup, I would watch for a sharp retracement toward support should enthusiasm wane or broader market risk-off pressure return."

Viktoras Karapetjanc, expert at Traders Union, finds Morpho’s uptrend well supported by a decisive break above all important moving averages. He believes investor conviction is robust, as shown by double-digit open interest growth, rising volumes, and a healthy long bias. The bullish market structure remains intact, with dynamic support and momentum pointing higher. He expects any retracements to offer new entries for buyers. "I see further growth ahead if Morpho holds above $2.19 — this market offers multiple setups for trend followers seeking momentum."

Overbought momentum emerges amid persistent session highs and bullish signals

MORPHO/USD is trading above its 20-day ($2.0044), 50-day ($1.9173), and 200-day ($1.5767) moving averages, confirming a clear bullish structure across short-, medium-, and long-term horizons. Immediate dynamic support sits at the Ichimoku Kijun level of $2.0020, with the next key resistance likely near the recent highs or the next round level above $2.41. Momentum readings on the Moving Average Convergence Divergence (MACD) are currently neutral, but the Average Directional Index (ADX) indicates renewed buying strength. The Relative Strength Index (RSI) signals bullish momentum, and both the Stochastic RSI and Commodity Channel Index (CCI) have entered overbought territory, suggesting the move is stretched. Bull/Bear Power (BBP) above zero confirms buyers are dominating intraday flows. The Awesome Oscillator (AO) also points to ongoing buying pressure. MORPHO/USD rose $0.235 or 10.80% today, opening with a clear upside gap of roughly $0.0690. The price now sits near the top of the day’s range with intraday volatility at 6.71%, showing persistent strength toward session highs. Oscillator warnings of overbought conditions diverge from still-bullish momentum readings, signaling enthusiasm could slow if short-term profits are taken.

Earlier, analysts noted that Morpho was exhibiting strong technical momentum and sustained buyer dominance. The latest surge in price and open interest reinforces this bullish narrative, making a move through the $2.56 resistance level a critical upside catalyst to watch in the coming sessions.

Source of Data: MORPHO Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.